Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones
- PMID: 19251140
- DOI: 10.1016/j.jcrs.2008.11.049
Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones
Abstract
Purpose: To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery.
Setting: Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan.
Methods: Eyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC(50), MIC(90), mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically.
Results: Of the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus, including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium. Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus, 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes (P<.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains (P>.05, McNemar test).
Conclusion: Because many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
Similar articles
-
Bacteriologic profile of the conjunctiva in the patients with dry eye.Am J Ophthalmol. 2008 Nov;146(5):729-34. doi: 10.1016/j.ajo.2008.06.003. Epub 2008 Jul 30. Am J Ophthalmol. 2008. PMID: 18672220
-
In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.Cornea. 2007 Feb;26(2):194-8. doi: 10.1097/01.ico.0000248379.78777.f6. Cornea. 2007. PMID: 17251812
-
In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.Eye Contact Lens. 2008 Mar;34(2):109-12. doi: 10.1097/ICL.0b013e31813c102a. Eye Contact Lens. 2008. PMID: 18327047
-
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.Adv Ther. 2008 Oct;25(10):979-94. doi: 10.1007/s12325-008-0107-x. Adv Ther. 2008. PMID: 18836691 Review.
-
Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.Surv Ophthalmol. 2004 Mar;49 Suppl 2:S79-83. doi: 10.1016/j.survophthal.2004.01.004. Surv Ophthalmol. 2004. PMID: 15028483 Review.
Cited by
-
The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria.Clin Ophthalmol. 2010 Apr 26;4:211-4. doi: 10.2147/opth.s9839. Clin Ophthalmol. 2010. PMID: 20463786 Free PMC article.
-
Risk factors for fluoroquinolone resistance in ocular cultures.Korean J Ophthalmol. 2015 Feb;29(1):7-13. doi: 10.3341/kjo.2015.29.1.7. Epub 2015 Jan 22. Korean J Ophthalmol. 2015. PMID: 25646055 Free PMC article. Clinical Trial.
-
Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis.J Clin Microbiol. 2013 Sep;51(9):2959-63. doi: 10.1128/JCM.00846-13. Epub 2013 Jul 3. J Clin Microbiol. 2013. PMID: 23824766 Free PMC article.
-
Drug delivery to the posterior segment of the eye for pharmacologic therapy.Expert Rev Ophthalmol. 2010 Feb 1;5(1):75-93. doi: 10.1586/eop.09.70. Expert Rev Ophthalmol. 2010. PMID: 20305803 Free PMC article.
-
Bacterial culture after three sterilization methods for cataract surgery.Jpn J Ophthalmol. 2013 Jan;57(1):74-9. doi: 10.1007/s10384-012-0201-0. Epub 2012 Oct 19. Jpn J Ophthalmol. 2013. PMID: 23080269 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical